Literature DB >> 14644489

Organ motion, set-up variation and treatment margins in radical radiotherapy of urinary bladder cancer.

Ludvig Paul Muren1, Rune Smaaland, Olav Dahl.   

Abstract

BACKGROUND AND
PURPOSE: A major challenge in conformal radiotherapy of bladder cancer is to determine adequate treatment margins. For this purpose, we therefore quantified the internal motion of the urinary bladder as well as the external patient set-up variation during a course of fractionated radiotherapy. In the light of the recently introduced ICRU-62 concept, the planning organ at risk volume, we also studied the internal motion of nearby organs at risk, the rectum and intestine.
MATERIAL AND METHODS: Weekly CT scans and electronic portal images (EPIs) were sampled from 20 patients during radical, conformal bladder irradiation (60-64 Gy/2 Gy in five fractions weekly). The planning scans were acquired with 70 ml of bladder contrast instilled, and patients were instructed to void before the treatment/repeat scanning sessions. Internal motion of the bladder, rectum and intestine was measured by 3-D image matching of the repeat scans to the patients' planning scans. Internal margins (CTV-to-ITV) were determined using both a direct empirical approach and an analytically derived margin recipe. The external patient set-up variability was determined by 2-D matching of front and lateral EPIs to corresponding digitally reconstructed radiographs.
RESULTS: A total of 149 CT scans (20 for planning, 129 during the treatment course) and 133 sets of EPIs were analysed. Bladder volumes were smaller during treatment than in the planning situation in 85% of the repeat scans. Nevertheless, we found the repeat scan bladder volumes to extend outside the planning scan bladder contours in 89% of the scans, on average with 9% of the volume (range: 0-47%). Eight patients (40%) had at least one repeat scan (25 scans in total) where displacements >15 mm were observed at one or more sides of the bladder. CTV-to-ITV margins of 10 mm inferior, 20 mm superior, 11 mm left, 8 mm right, 20 mm anterior and 14 mm posterior were required to simultaneously encompass all bladder deflections except for the largest outward deflection in all directions in 84% of the patients. Including patient set-up variation (CTV-to-PTV), we found that an additional safety margin of 2-6 mm had to be added in the various directions. The rectum expanded outside the planning contours in all repeat scans, on average with 24% of the volume (range: 2-69%). The volume of intestine found close to the bladder were significantly and negatively correlated to the bladder volume in almost half of the patients.
CONCLUSION: This study documented both a large internal motion of the bladder and a substantial patient set-up variation. Our current treatment margins have been adjusted according to the findings of this study. Considerable variation in position and volume of the rectum and intestine was also documented.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14644489     DOI: 10.1016/s0167-8140(03)00246-9

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  22 in total

Review 1.  Radiation dose-volume effects of the urinary bladder.

Authors:  Akila N Viswanathan; Ellen D Yorke; Lawrence B Marks; Patricia J Eifel; William U Shipley
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

2.  Sensitivity of postplanning target and OAR coverage estimates to dosimetric margin distribution sampling parameters.

Authors:  Huijun Xu; J James Gordon; Jeffrey V Siebers
Journal:  Med Phys       Date:  2011-02       Impact factor: 4.071

3.  Variability in bladder volumes of full bladders in definitive radiotherapy for cases of localized prostate cancer.

Authors:  Naoki Nakamura; Naoto Shikama; Osamu Takahashi; Makiko Ito; Masatoshi Hashimoto; Masahiro Uematsu; Yukihiro Hama; Kenji Sekiguchi; Keiichi Nakagawa
Journal:  Strahlenther Onkol       Date:  2010-11-08       Impact factor: 3.621

4.  Assessing organ at risk position variation and its impact on delivered dose in kidney SABR.

Authors:  Mathieu Gaudreault; Shankar Siva; Tomas Kron; Nicholas Hardcastle
Journal:  Radiat Oncol       Date:  2022-06-27       Impact factor: 4.309

5.  Intensity-modulated radiation therapy (IMRT) vs. 3D conformal radiotherapy (3DCRT) in locally advanced rectal cancer (LARC): dosimetric comparison and clinical implications.

Authors:  Leire Arbea; Luis Isaac Ramos; Rafael Martínez-Monge; Marta Moreno; Javier Aristu
Journal:  Radiat Oncol       Date:  2010-02-26       Impact factor: 3.481

6.  Independent position correction on tumor and lymph nodes; consequences for bladder cancer irradiation with two combined IMRT plans.

Authors:  Dominique C van Rooijen; René Pool; Jeroen B van de Kamer; Maarten C C M Hulshof; Caro C E Koning; Arjan Bel
Journal:  Radiat Oncol       Date:  2010-06-15       Impact factor: 3.481

7.  Dosimetric impact of intrafractional patient motion in pediatric brain tumor patients.

Authors:  Chris Beltran; John Trussell; Thomas E Merchant
Journal:  Med Dosim       Date:  2009-02-07       Impact factor: 1.482

8.  Using cone-beam computed tomography to evaluate the impact of bladder filling status on target position in prostate radiotherapy.

Authors:  Chiao-Ling Tsai; Jian-Kuen Wu; Chun-Wei Wang; Feng-Ming Hsu; Ming-Kuen Lai; Jason Chia-Hsien Cheng
Journal:  Strahlenther Onkol       Date:  2009-09-12       Impact factor: 3.621

9.  The effect of on-line position correction on the dose distribution in focal radiotherapy for bladder cancer.

Authors:  Dominique C van Rooijen; Jeroen B van de Kamer; René Pool; Maarten C C M Hulshof; Caro C E Koning; Arjan Bel
Journal:  Radiat Oncol       Date:  2009-09-24       Impact factor: 3.481

10.  Image-Guided Radiation Therapy for Muscle-Invasive Carcinoma of the Urinary Bladder with Cone Beam CT Scan: Use of Individualized Internal Target Volumes for a Single Patient.

Authors:  Gagan Saini; Anchal Aggarwal; Roopam Srivastava; Pramod K Sharma; Madhur Garg; Sapna Nangia; Manish Chomal
Journal:  Case Rep Oncol       Date:  2012-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.